PPAPDC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
5.47979994713899E-10 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
3.26849658449646E-11 |
Stage1-vs-Stage2 |
8.469800E-01 |
Stage1-vs-Stage3 |
5.397700E-02 |
Stage1-vs-Stage4 |
4.905200E-01 |
Stage2-vs-Stage3 |
1.340250E-01 |
Stage2-vs-Stage4 |
4.877400E-01 |
Stage3-vs-Stage4 |
5.446400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
2.5003000000412E-06 |
Normal-vs-Asian |
1.827350E-01 |
Caucasian-vs-AfricanAmerican |
1.157830E-01 |
Caucasian-vs-Asian |
2.851600E-02 |
AfricanAmerican-vs-Asian |
3.021200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
4.97609953242772E-10 |
Male-vs-Female |
9.77380000000139E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.77099999612673E-08 |
Normal-vs-Age(41-60Yrs) |
1.63258295771129E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
7.95000000053392E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.770000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.972800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.059600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.834440E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.107600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.671800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.436200E-02 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.76580972066631E-12 |
Grade 1-vs-Grade 2 |
4.772800E-01 |
Grade 1-vs-Grade 3 |
2.724400E-01 |
Grade 1-vs-Grade 4 |
8.677800E-02 |
Grade 2-vs-Grade 3 |
5.514100E-02 |
Grade 2-vs-Grade 4 |
3.520000E-02 |
Grade 3-vs-Grade 4 |
3.534400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62436730732907E-12 |
Normal-vs-ccB subtype |
1.62436730732907E-12 |
ccA subtype-vs-ccB subtype |
7.004700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62481139653892E-12 |
Normal-vs-N1 |
1.3182000002665E-07 |
N0-vs-N1 |
2.078600E-01 |
|
|